account_balance
Investment manager · 13F filer · SEC CIK 2006045
SymBiosis Capital Partners, LLC
Reported value$52.8Mas of Mar 31, 2026
Positions6
Top 10 weight100.0%EVMN alone is 56%
FiledMay 1242 days after quarter end
Portfolio · as of Mar 31, 2026
Where the money is
This fund reports 6 stocks.
EVMNEvommune, Inc.
55.8%
IVAInventiva S.A.
24.8%
WVEWave Life Sciences Ltd.
10.3%
RANIRani Therapeutics Holdings, Inc.
5.1%
CLNNClene Nanomedicine Inc.
4.0%
Box size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.